{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:06:37Z","timestamp":1792292797774,"version":"4.4.0"},"reference-count":52,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T00:00:00Z","timestamp":1585440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI110329"],"award-info":[{"award-number":["R01AI110329"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI143521"],"award-info":[{"award-number":["R01AI143521"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>With the continued loss of antimalarials to resistance, drug repositioning may have a role in maximising efficiency and accelerating the discovery of new antimalarial drugs. Bayesian statistics was previously used as a tool to virtually screen USFDA approved drugs for predicted \u03b2-haematin (synthetic haemozoin) inhibition and in vitro antimalarial activity. Here, we report the experimental evaluation of nine of the highest ranked drugs, confirming the accuracy of the model by showing an overall 93% hit rate. Lapatinib, nilotinib, and lomitapide showed the best activity for inhibition of \u03b2-haematin formation and parasite growth and were found to inhibit haemozoin formation in the parasite, providing mechanistic insights into their mode of antimalarial action. We then screened the USFDA approved drugs for binding to the \u03b2-haematin crystal, applying a docking method in order to evaluate its performance. The docking method correctly identified imatinib, lapatinib, nilotinib, and lomitapide. Experimental evaluation of 22 of the highest ranked purchasable drugs showed a 24% hit rate. Lapatinib and nilotinib were chosen as templates for shape and electrostatic similarity screening for lead hopping using the in-stock ChemDiv compound catalogue. The actives were novel structures worthy of future investigation. This study presents a comparison of different in silico methods to identify new haemozoin-inhibiting chemotherapeutic alternatives for malaria that proved to be useful in different ways when taking into consideration their strengths and limitations.<\/jats:p>","DOI":"10.3390\/molecules25071571","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T05:55:16Z","timestamp":1585893316000},"page":"1571","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites"],"prefix":"10.3390","volume":"25","author":[{"given":"Ana Carolina C.","family":"de Sousa","sequence":"first","affiliation":[{"name":"Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch 7701, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keletso","family":"Maepa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pharmacology, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Combrinck","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pharmacology, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Institute of Infectious Disease and Molecular Medicine, Wellcome Centre for Infectious Diseases Research in Africa, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Egan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch 7701, South Africa"},{"name":"Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch 7701, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,29]]},"reference":[{"key":"ref_1","unstructured":"WHO (2018). World Malaria Report 2018, World Health Organisation. Available online: https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2018\/report\/en\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/cb300454t","article-title":"Insights into the role of heme in the mechanism of action of antimalarials","volume":"8","author":"Combrinck","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1021\/cg025550i","article-title":"Quinoline binding site on malaria pigment crystal: A rational pathway for antimalaria drug design","volume":"2","author":"Buller","year":"2002","journal-title":"Cryst. Growth Des."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1073\/pnas.1501023112","article-title":"Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine","volume":"112","author":"Olafson","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.1700125114","article-title":"Antimalarials inhibit hematin crystallization by unique drug-surface site interactions","volume":"114","author":"Olafson","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the p. Falciparum digestive vacuole transmembrane protein pfcrt and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol. Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsinfecdis.7b00211","article-title":"Efforts aimed to reduce attrition in antimalarial drug discovery: A systematic evaluation of the current antimalarial targets portfolio","volume":"4","author":"Chaparro","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"18732","DOI":"10.3390\/molecules201018732","article-title":"Charting a path to success in virtual screening","volume":"20","author":"Forli","year":"2015","journal-title":"Molecules"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cpch.27","article-title":"Overview of methods and strategies for conducting virtual small molecule screening","volume":"9","author":"Fradera","year":"2017","journal-title":"Curr. Protoc. Chem. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nature03197","article-title":"Virtual screening of chemical libraries","volume":"432","author":"Shoichet","year":"2004","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.compbiolchem.2018.06.005","article-title":"Docking techniques in pharmacology: How much promising?","volume":"76","author":"Gupta","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/17460441.2019.1604677","article-title":"The compromise of virtual screening and its impact on drug discovery","volume":"14","author":"Slater","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1038\/s41598-020-60221-0","article-title":"Virtual screening as a tool to discover new \u03b2-haematin inhibitors with activity against malaria parasites","volume":"10","author":"Combrinck","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.drudis.2006.05.012","article-title":"Virtual ligand screening: Strategies, perspectives and limitations","volume":"11","author":"Klebe","year":"2006","journal-title":"Drug Discov. Today"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/j.bmc.2014.12.020","article-title":"Bayesian models trained with hts data for predicting beta-haematin inhibition and in vitro antimalarial activity","volume":"23","author":"Wicht","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1128\/AAC.00121-11","article-title":"Use of the np-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization","volume":"55","author":"Sandlin","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.ejmech.2009.09.012","article-title":"A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity","volume":"44","author":"Guglielmo","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/138620710790980496","article-title":"Lipophilic mediated assays for beta-hematin inhibitors","volume":"13","author":"Carter","year":"2010","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijpddr.2014.08.002","article-title":"Identification of beta-hematin inhibitors in a high-throughput screening effort reveals scaffolds with in vitro antimalarial activity","volume":"4","author":"Sandlin","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ab.2004.11.022","article-title":"A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds","volume":"338","author":"Ncokazi","year":"2005","journal-title":"Anal. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejmech.2018.09.060","article-title":"Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites","volume":"159","author":"Muller","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1039\/C6OB02110G","article-title":"Shining new light on ancient drugs: Preparation and subcellular localisation of novel fluorescent analogues of cinchona alkaloids in intraerythrocytic plasmodium falciparum","volume":"15","author":"Woodland","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1021\/acschembio.8b00583","article-title":"Chemical proteomics and super-resolution imaging reveal that chloroquine interacts with plasmodium falciparum multidrug resistance-associated protein and lipids","volume":"13","author":"Woodland","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/187152610791163354","article-title":"Leveraging cell cycle analysis in anticancer drug discovery to identify novel plasmodial drug targets","volume":"10","author":"Kozlov","year":"2010","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","article-title":"Kinase-targeted cancer therapies: Progress, challenges and future directions","volume":"17","author":"Bhullar","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1021\/acs.jmedchem.8b00329","article-title":"Plasmodial kinase inhibitors: License to cure?","volume":"61","author":"Cabrera","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcmd.2015.05.007","article-title":"Tyrosine kinase inhibitors: New class of antimalarials on the horizon?","volume":"55","author":"Pathak","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kesely, K.R., Pantaleo, A., Turrini, F.M., Olupot-Olupot, P., and Low, P.S. (2016). Inhibition of an erythrocyte tyrosine kinase with imatinib prevents plasmodium falciparum egress and terminates parasitemia. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164895"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1475-2875-13-143","article-title":"Repositioning: The fast track to new anti-malarial medicines?","volume":"13","author":"Lotharius","year":"2014","journal-title":"Malar. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ja.2015.7","article-title":"Antimalarial activity of kinase inhibitor, nilotinib, in vitro and in vivo","volume":"68","author":"Ishiyama","year":"2015","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"Zinc\u2014A free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with pyrx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1073\/pnas.1118370109","article-title":"Liver-stage malaria parasites vulnerable to diverse chemical scaffolds","volume":"109","author":"Derbyshire","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcp.12612","article-title":"Lomitapide","volume":"80","author":"Goulooze","year":"2015","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1021\/cr500098f","article-title":"Recent approaches to chemical discovery and development against malaria and the neglected tropical diseases human african trypanosomiasis and schistosomiasis","volume":"114","author":"Njoroge","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"iv","DOI":"10.1016\/j.coph.2018.09.002","article-title":"Editorial overview: Tuberculosis, malaria and schistosomiasis; understanding resistance and development of new drugs","volume":"42","author":"Egan","year":"2018","journal-title":"Curr. Opin. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijpddr.2016.12.005","article-title":"Effect of clinically approved hdac inhibitors on plasmodium, leishmania and schistosoma parasite growth","volume":"7","author":"Chua","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1128\/AAC.44.10.2638-2644.2000","article-title":"Hematin polymerization assay as a high-throughput screen for identification of new antimalarial pharmacophores","volume":"44","author":"Kurosawa","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.01466-08","article-title":"Colorimetric high-throughput screen for detection of heme crystallization inhibitors","volume":"53","author":"Rush","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpddr.2015.05.003","article-title":"Identification of beta-hematin inhibitors in the mmv malaria box","volume":"5","author":"Fong","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e01607-16","DOI":"10.1128\/AAC.01607-16","article-title":"High-throughput screening and prediction model building for novel hemozoin inhibitors using physicochemical properties","volume":"61","author":"Huy","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12936-015-0729-9","article-title":"Optimization of a multi-well colorimetric assay to determine haem species in plasmodium falciparum in the presence of anti-malarials","volume":"14","author":"Combrinck","year":"2015","journal-title":"Malar. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"Datawarrior: An open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cbpa.2006.04.002","article-title":"Structure-based virtual screening of chemical libraries for drug discovery","volume":"10","author":"Ghosh","year":"2006","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nchembio.150","article-title":"Identification of a chemical probe for naadp by virtual screening","volume":"5","author":"Naylor","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/jm040163o","article-title":"A shape-based 3-d scaffold hopping method and its application to a bacterial protein-protein interaction","volume":"48","author":"Rush","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Da Costa, G.V., Ferreira, E.F.B., Ramos, R.S., da Silva, L.B., de Sa, E.M.F., da Silva, A.K.P., Lobato, C.M., Souto, R.N.P., da Silva, C.H.T.P., and Federico, L.B. (2019). Hierarchical virtual screening of potential insectides inhibitors of acetylcholinesterase and juvenile hormone from temephos. Pharmaceuticals (Basel), 12.","DOI":"10.3390\/ph12020061"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.1993.48.739","article-title":"Parasite lactate dehydrogenase as an assay for plasmodium falciparum drug sensitivity","volume":"48","author":"Makler","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35005132","article-title":"The structure of malaria pigment (\u03b2-haematin)","volume":"404","author":"Pagola","year":"2000","journal-title":"Nature"},{"key":"ref_52","unstructured":"Schrodinger, LLC (2015). The Pymol Molecular Graphics System, Schr\u00f6dinger. version 2.2.0."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/7\/1571\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:13:10Z","timestamp":1760173990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/7\/1571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,29]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["molecules25071571"],"URL":"https:\/\/doi.org\/10.3390\/molecules25071571","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,29]]}}}